September 6, 2024 07:00 AM EDT
Peer Review

Roche's Spark los­es CEO to RNA up­start; Ex-El­e­va­tion On­col­o­gy chief takes over at Af­fimed

Alex Hoffman

Senior Editor

Kathy Wong

Editor

→ Ron Philip has stepped down as CEO at Roche’s Spark to run the show at Or­bital Ther­a­peu­tics, an RNA biotech tied to Beam Ther­a­peu­tics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

Scor­pi­on de­tails ear­ly da­ta on tar­get­ed breast can­cer drug as it seeks to chal­lenge No­var­tis, Roche

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

Post-Hoc: Big promis­es built Mod­er­na. They might al­so be its un­do­ing

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

A service from the Financial Times